References
- 1WohlfarthKMullerCSassinIComesGGrafeSNeurophysiological double-blind trial of a botulinum neurotoxin type a free of complexing proteinsClin Neuropharmacol200730869410.1097/01.WNF.0000240951.18821.5017414940
- 2FosterKABigalkeHAokiKRBotulinum neurotoxin—from laboratory to bedsideNeurotox Res2006913314010.1007/BF0303393116785110
- 3TugnoliVEleopraRMontecuccoCDe GrandisDThe therapeutic use of botulinum toxinExpert Opin Investig Drugs199761383139410.1517/13543784.6.10.1383
- 4BakheitAMWardCDMcLellanDLGeneralised botulism-like syndrome after intramuscular injections of botulinum toxin type A: a report of two casesJ Neurol Neurosurg Psychiatry19976219810.1136/jnnp.62.2.1989048725
- 5BhatiaKPMunchauAThompsonPDet alGeneralised muscular weakness after botulinum toxin injections for dystonia: a report of three casesJ Neurol Neurosurg Psychiatry199967909310.1136/jnnp.67.1.9010369829
- 6U.S. Food and Drug AdministrationBotox and Botox Cosmetic (botulinum toxin type A) and Myobloc (botulinum toxin type B)2009 [cited 2011 December 29]; Available from: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm164255.htm
- 7EleopraRTugnoliVCaniattiLDe GrandisDBotulinum toxin treatment in the facial muscles of humans: evidence of an action in untreated near muscles by peripheral local diffusionNeurology1996461158116010.1212/WNL.46.4.11588780112
- 8EleopraRTugnoliVQuatraleRRossettoOMontecuccoCDifferent types of botulinum toxin in humansMov Disord200419(Suppl 8)S535910.1002/mds.2001015027055
- 9FlynnTCClarkRE
2nd Botulinum toxin type B (MYOBLOC) versus botulinum toxin type A (BOTOX) frontalis study: rate of onset and radius of diffusionDermatol Surg20032951952210.1046/j.1524-4725.2003.29124.x12752521 - 10HsuTSDoverJSArndtKAEffect of volume and concentration on the diffusion of botulinum exotoxin AArch Dermatol20041401351135410.1001/archderm.140.11.135115545544
- 11RosalesRLBigalkeHDresslerDPharmacology of botulinum toxin: differences between type A preparationsEur J Neurol200613 Suppl 121016417591
- 12YaraskavitchMLeonardTHerzogWBotox produces functional weakness in non-injected muscles adjacent to the target muscleJ Biomech20084189790210.1016/j.jbiomech.2007.11.01618184613
- 13ShaariCMGeorgeEWuBLBillerHFSandersIQuantifying the spread of botulinum toxin through muscle fasciaLaryngoscope199110196096410.1288/00005537-199109000-000061886444
- 14BorodicGEJosephMFayLCozzolinoDFerranteRJBotulinum A toxin for the treatment of spasmodic torticollis: dysphagia and regional toxin spreadHead Neck19901239239910.1002/hed.28801205042211099
- 15BorodicGEFerranteRPearceLBSmithKHistologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injectionsMov Disord19949313910.1002/mds.8700901068139603
- 16BuchmanASComellaCLStebbinsGTTannerCMGoetzCGQuantitative electromyographic analysis of changes in muscle activity following botulinum toxin therapy for cervical dystoniaClin Neuropharmacol19931620521010.1097/00002826-199306000-000038504437
- 17CarliLMontecuccoCRossettoOAssay of diffusion of different botulinum neurotoxin type a formulations injected in the mouse legMuscle Nerve20094037438010.1002/mus.2134319618426
- 18LorenzanoCBagnatoSGilioFFabbriniGBerardelliANo clinical or neurophysiological evidence of botulinum toxin diffusion to non-injected muscles in patients with hemifacial spasmNeurotox Res2006914114410.1007/BF0303393216785111
- 19CarliLMontecuccoCRossettoOAn histological assessment of diffusion of different botulinum neurotoxin type A formulations injected in the mice legToxicon200851(Suppl)9
- 20Tang-LiuDDAokiKRDollyJOet alIntramuscular injection of 125I-botulinum neurotoxin-complex versus 125I-botulinum-free neurotoxin: time course of tissue distributionToxicon20034246146910.1016/S0041-0101(03)00196-X14529727
- 21PickettADoddSRzanyBConfusion about diffusion and the art of misinterpreting data when comparing different botulinum toxins used in aesthetic applicationsJ Cosmet Laser Ther20081018118310.1080/1476417080209428218608706
- 22GlogauRGReview of the use of botulinum toxin for hyperhidrosis and cosmetic purposesClin J Pain200218S19119712569968
- 23GoodmanGDiffusion and short-term efficacy of botulinum toxin A after the addition of hyaluronidase and its possible application for the treatment of axillary hyperhidrosisDermatol Surg20032953353810.1046/j.1524-4725.2003.29126.x12752524
- 24LimECSeetRCBotulinum toxin: description of injection techniques and examination of controversies surrounding toxin diffusionActa Neurol Scand2008117738417850405
- 25de AlmeidaATDe BoulleKDiffusion characteristics of botulinum neurotoxin products and their clinical significance in cosmetic applicationsJ Cosmet Laser Ther20079(Suppl 1)172210.1080/1742959070152379417885882
- 26KinnettDBotulinum toxin A injections in children: technique and dosing issuesAm J Phys Med Rehabil200483S596410.1097/01.PHM.0000141131.66648.E915448579
- 27WohlfarthKSchwandtIWegnerFet alBiological activity of two botulinum toxin type A complexes (Dysport and Botox) in volunteers: a double-blind, randomized, dose-ranging studyJ Neurol20082551932193918854916
- 28DresslerDRoutine use of Xeomin in patients previously treated with Botox: long term resultsEur J Neurol200916(Suppl 2)2520002739
- 29EiseleKHTaylorHVDissociation of the 900 kDa neurotoxin complex from c. botulinum under physiological conditionsToxicon200851(Suppl 1)1018045635
- 30FrevertJXeomin is free from complexing proteinsToxicon20095469770110.1016/j.toxicon.2009.03.01019292989
- 31WohlfarthKSychaTRanouxDNaverHCairdDDose equivalence of two commercial preparations of botulinum neurotoxin type A: time for a reassessmentCurr Med Res Opin2009251573158410.1185/0300799090302820319463043
- 32DresslerDComparing Botox and Xeomin for axillar hyperhidrosisJ Neural Transm201011731731910.1007/s00702-010-0372-020143241
- 33BrinMFLyonsKEDoucetteJet alA randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremorNeurology2001561523152810.1212/WNL.56.11.152311402109
- 34SimpsonDMGraciesJMYablonSABarbanoRBrashearABotulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled studyJ Neurol Neurosurg Psychiatry20098038038510.1136/jnnp.2008.15965718977811
- 35MolloyFMShillHAKaelin-LangAKarpBIAccuracy of muscle localization without EMG: implications for treatment of limb dystoniaNeurology20025880580710.1212/WNL.58.5.80511889247
- 36ComellaCLBuchmanASTannerCMBrown-TomsNCGoetzCGBotulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistanceNeurology19924287888210.1212/WNL.42.4.8781565246
- 37GeenenCConskyEAshbyPLocalizing muscles for botulinum toxin treatment of focal hand dystoniaCan J Neurol Sci1996231941978862841
- 38DoguOApaydinDSevimSTalasDUAralMUltrasound-guided versus ‘blind’ intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's diseaseClin Neurol Neurosurg2004106939610.1016/j.clineuro.2003.10.01215003297
- 39SconfienzaLMLacelliFBrunoASerafiniGUltrasound guidance can improve the outcome of botulinum toxin A injectionEur J Phys Rehabil Med20094515319282806
- 40AokiKRA comparison of the safety margins of botulinum neurotoxin serotypes A, B, and F in miceToxicon2001391815182010.1016/S0041-0101(01)00101-511600142
- 41AokiKRBotulinum neurotoxin serotypes A and B preparations have different safety margins in preclinical models of muscle weakening efficacy and systemic safetyToxicon20024092392810.1016/S0041-0101(02)00086-712076646
- 42NüssgensZRoggenkämperPComparison of two botulinum-toxin preparations in the treatment of essential blepharospasmGraefes Arch Clin Exp Ophthalmol199723519719910.1007/BF009417589143885
- 43RanouxDGuryCFondaraiJMasJLZuberMRespective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystoniaJ Neurol Neurosurg Psychiatry20027245946211909903
- 44OdergrenTHjaltasonHKaakkolaSet alA double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystoniaJ Neurol Neurosurg Psychiatry19986461210.1136/jnnp.64.1.69436720
- 45SampaioCCostaJFerreiraJJClinical comparability of marketed formulations of botulinum toxinMov Disord200419 Suppl 8S12913610.1002/mds.2006615027065
- 46LowePPatnaikRLoweNComparison of two formulations of botulinum toxin type A for the treatment of glabellar lines: a double-blind, randomized studyJ Am Acad Dermatol20065597598010.1016/j.jaad.2006.07.00617097394
- 47RoggenkämperPJostWHBihariKComesGGrafeSEfficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasmJ Neural Transm200611330331210.1007/s00702-005-0323-315959841
- 48BeneckeRJostWHKanovskyPRuzickaEComesGGrafeSA new botulinum toxin type A free of complexing proteins for treatment of cervical dystoniaNeurology2005641949195110.1212/01.WNL.0000163767.99354.C315955951
- 49FrevertJXeomin: an innovative new botulinum toxin type AEur J Neurol200916(Suppl 2)111310.1111/j.1468-1331.2009.02879.x20002741
- 50JostWHEfficacy and safety of botulinum neurotoxin type A free of complexing proteins (NT 201) in cervical dystonia and blepharospasmFuture Neurol2007248549310.2217/14796708.2.5.485
- 51KerscherMMaackMReutherTKrügerNDiffusion characteristics of two different neurotoxins in patients with symmetric forehead linesJ Am Acad Dermatol200756AB199
- 52ComellaCLJankovicJShannonKMet alComparison of botulinum toxin serotypes A and B for the treatment of cervical dystoniaNeurology2005651423142910.1212/01.wnl.0000183055.81056.5c16275831
- 53PappertEJGermansonTBotulinum toxin type B vs. type A in toxin-naive patients with cervical dystonia: Randomized, double-blind, noninferiority trialMov Disord20082351051710.1002/mds.2172418098274
- 54ChapmanMABarronRTanisDCGillCECharlesPDComparison of botulinum neurotoxin preparations for the treatment of cervical dystoniaClin Ther2007291325133710.1016/j.clinthera.2007.07.02017825685
- 55ComellaCLJankovicJBrinMFUse of botulinum toxin type A in the treatment of cervical dystoniaNeurology200055S152111188979
- 56LeeLHChangWNChangCSThe finding and evaluation of EMG-guided BOTOX injection in cervical dystoniaActa Neurol Taiwan200413717615478678